21+

Age Verification Required

You must be 21 years of age or older to enter this site. All products are for research use only and not intended for human consumption.

≥99% Purity GuaranteedThird-Party Lab TestedCOA With Every OrderSame-Day Shipping Before 3PMHeavy Metals & Sterility TestedHPLC Verified≥99% Purity GuaranteedThird-Party Lab TestedCOA With Every OrderSame-Day Shipping Before 3PMHeavy Metals & Sterility TestedHPLC Verified
Prime 9 Labs
HomeShopCOA LibraryFAQContact
Tesamorelin 10mg

Tesamorelin

Synthetic GHRH Analog · Lyophilized Powder

$125
per vial · 10mg
≥99% Purity
3rd Party Tested
COA Available
Sterility Tested

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) used in research studying the pituitary GH axis, visceral adipose tissue regulation, and growth hormone secretagogue mechanisms in laboratory settings.

Size
Amount
1 Vial
Full price
Most Popular
2 Vials
Save 10%
Best Value
3 Vials
Save 15%

For Research Use Only · Not for Human Consumption

Product Overview

Tesamorelin is a synthetic peptide analogue of GHRH (growth hormone-releasing hormone) that stimulates the pituitary somatotroph cells to produce and release growth hormone. It has been studied extensively in the context of the hypothalamic–pituitary–somatotropic axis and metabolic research.

Supplied as lyophilized powder at ≥99% purity by HPLC. Full batch COA included with every order.

Compound Details

  • Full name: trans-3-hexenoic acid–GRF(1–44)–NH₂
  • Molecular weight: 5135.9 g/mol
  • CAS Number: 218949-48-9
  • Form: White lyophilized powder
  • Storage: −20°C, dry, protect from light

Research Background

Tesamorelin acts on GHRH receptors in the pituitary gland, stimulating the production and release of growth hormone. Researchers use it to study GH axis signaling, body composition changes in experimental models, and adipose tissue biology.

Areas of Study

  • GHRH receptor activation and GH pulse dynamics
  • Pituitary somatotroph cell function and GH secretion
  • Visceral adipose tissue remodeling in cell and animal models
  • IGF-1 axis regulation downstream of GH release
  • Lipid metabolism and lipolysis signaling pathways
  • HPA axis cross-talk with the somatotropic axis

For research use only. Consult relevant literature and institutional protocols before use.

Certificate of Analysis

Tesamorelin

Tesamorelin Acetate

Certificate No. CP-QCC-2026-041806
Lot Number TSM-APR26-M8C5Q1
Release Date 2026.04.19
Product NameTesamorelin
CAS No.218949-48-5
TypeSynthetic peptide
Country of OriginUnited States
Physical FormWhite lyophilized powder
Date of Analysis2026.04.18
Storage-20°C, light-protected, dry
Retest Date2028.04.16
UseLaboratory Research Only
Lot NumberTSM-APR26-M8C5Q1

Amino Acid Sequence

Y-A-D-A-I-F-T-N-S-Y-R-K-V-L-G-Q-L-S-A-R-K-L-L-Q-D-I-M-S-R-Q-Q-G-E-S-N-Q-E-R-G-A-R-A-R-L

44-mer N-terminally modified human GHRH(1-44) analog; acetate salt form confirmed

Test ParameterSpecificationResult
AppearanceConforms to specification: White lyophilized powderPASS — White lyophilized powder
Purity / Assay≥99.0% (HPLC)PASS — 99.4%
IdentityConforms to reference standard (MS / HPLC)PASS — Confirmed
SolubilitySoluble in sterile waterPASS — Clear solution
RELEASED FOR DISTRIBUTION  ·  Lot: TSM-APR26-M8C5Q1  ·  Release Date: 2026.04.19